Protein Description

Gene Symbol NOS3
Entrez ID 4846
Uniprot ID P29474
Description nitric oxide synthase 3
Chromosomal Location chr7: 150,990,995-151,014,588
Ontology GO ID GO Term Definition Evidence

BP

GO:0001525

angiogenesis

Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.

IEA

BP

GO:0001542

ovulation from ovarian follicle

The process leading to the rupture of the follicle, releasing the centrally located oocyte into the oviduct. An example of this is found in Mus musculus.

IEA

BP

GO:0001701

in utero embryonic development

The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.

IEA

BP

GO:0001974

blood vessel remodeling

The reorganization or renovation of existing blood vessels.

ISS

BP

GO:0002028

regulation of sodium ion transport

Any process that modulates the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

IEA

BP

GO:0003057

regulation of the force of heart contraction by chemical signal

The regulation of the force of heart muscle contraction mediated by chemical signaling, hormonal, autocrine or paracrine.

IEA

BP

GO:0003100

regulation of systemic arterial blood pressure by endothelin

The process in which endothelin modulates the force with which blood passes through the circulatory system. Endothelin is a hormone that is released by the endothelium, and it is a vasoconstrictor.

IMP

BP

GO:0006527

arginine catabolic process

The chemical reactions and pathways resulting in the breakdown of arginine, 2-amino-5-(carbamimidamido)pentanoic acid.

IDA

BP

GO:0006809

nitric oxide biosynthetic process

The chemical reactions and pathways resulting in the formation of nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water.

IDA

BP

GO:0007005

mitochondrion organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution, and replication of the mitochondrial genome as well as synthesis of new mitochondrial components.

ISS

BP

GO:0007263

nitric oxide mediated signal transduction

Any intracellular signal transduction in which the signal is passed on within the cell via nitric oxide (NO). Includes synthesis of nitric oxide, receptors/sensors for nitric oxide (such as soluble guanylyl cyclase/sGC) and downstream effectors that further transmit the signal within the cell. Nitric oxide transmits its downstream effects through either cyclic GMP (cGMP)-dependent or independent mechanisms.

IBA

BP

GO:0008217

regulation of blood pressure

Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.

NAS

BP

GO:0008285

negative regulation of cell proliferation

Any process that stops, prevents or reduces the rate or extent of cell proliferation.

ISS

BP

GO:0009408

response to heat

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.

NAS

BP

GO:0010544

negative regulation of platelet activation

Any process that decreases the rate or frequency of platelet activation. Platelet activation is a series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue.

NAS

BP

GO:0014740

negative regulation of muscle hyperplasia

Any process that stops, prevents, or reduces the frequency, rate, or extent of muscle hyperplasia.

ISS

BP

GO:0014806

smooth muscle hyperplasia

A process, occurring in smooth muscle, in which there is an increase in cell number by cell division, often leading to an increase in the size of an organ.

ISS

BP

GO:0019430

removal of superoxide radicals

Any process, acting at the cellular level, involved in removing superoxide radicals (O2-) from a cell or organism, e.g. by conversion to dioxygen (O2) and hydrogen peroxide (H2O2).

IDA

BP

GO:0030324

lung development

The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.

IEA

BP

GO:0031284

positive regulation of guanylate cyclase activity

Any process that activates or increases the frequency, rate or extent of guanylate cyclase activity.

IMP|ISS

BP

GO:0031663

lipopolysaccharide-mediated signaling pathway

A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.

IEA

BP

GO:0034405

response to fluid shear stress

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface.

IEP

BP

GO:0043267

negative regulation of potassium ion transport

Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of potassium ions (K+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

IEA

BP

GO:0043542

endothelial cell migration

The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.

IMP

BP

GO:0045454

cell redox homeostasis

Any process that maintains the redox environment of a cell or compartment within a cell.

TAS

BP

GO:0045766

positive regulation of angiogenesis

Any process that activates or increases angiogenesis.

ISS

BP

GO:0045776

negative regulation of blood pressure

Any process in which the force of blood traveling through the circulatory system is decreased.

IBA

BP

GO:0045909

positive regulation of vasodilation

Any process that activates or increases the frequency, rate or extent of vasodilation.

IBA|NAS

BP

GO:0050880

regulation of blood vessel size

Any process that modulates the size of blood vessels.

ISS|NAS

BP

GO:0050999

regulation of nitric-oxide synthase activity

Any process that modulates the activity of the enzyme nitric-oxide synthase.

TAS

BP

GO:0051346

negative regulation of hydrolase activity

Any process that stops or reduces the rate of hydrolase activity, the catalysis of the hydrolysis of various bonds.

IEA

BP

GO:0051926

negative regulation of calcium ion transport

Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

IEA

BP

GO:0055114

oxidation-reduction process

A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.

IEA

BP

GO:1902042

negative regulation of extrinsic apoptotic signaling pathway via death domain receptors

Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.

ISS

CC

GO:0000139

Golgi membrane

The lipid bilayer surrounding any of the compartments of the Golgi apparatus.

TAS

CC

GO:0005634

nucleus

A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

ISS

CC

GO:0005737

cytoplasm

All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

IDA

CC

GO:0005829

cytosol

The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.

TAS

CC

GO:0005856

cytoskeleton

Any of the various filamentous elements that form the internal framework of cells, and typically remain after treatment of the cells with mild detergent to remove membrane constituents and soluble components of the cytoplasm. The term embraces intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles.

IEA

CC

GO:0005886

plasma membrane

The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

TAS

CC

GO:0005901

caveola

A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm.

IDA

CC

GO:0030666

endocytic vesicle membrane

The lipid bilayer surrounding an endocytic vesicle.

TAS

MF

GO:0003785

actin monomer binding

Interacting selectively and non-covalently with monomeric actin, also known as G-actin.

IPI

MF

GO:0004517

nitric-oxide synthase activity

Catalysis of the reaction: L-arginine + n NADPH + n H+ + m O2 = citrulline + nitric oxide + n NADP+.

IDA|IMP|TAS

MF

GO:0005506

iron ion binding

Interacting selectively and non-covalently with iron (Fe) ions.

IEA

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0005516

calmodulin binding

Interacting selectively and non-covalently with calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states.

IEA

MF

GO:0010181

FMN binding

Interacting selectively and non-covalently with flavin mono nucleotide. Flavin mono nucleotide (FMN) is the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.

NAS

MF

GO:0020037

heme binding

Interacting selectively and non-covalently with heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring.

IDA

MF

GO:0034617

tetrahydrobiopterin binding

Interacting selectively and non-covalently with a tetrahydrobiopterin, 5,6,7,8-tetrahydrobiopterin or a derivative thereof; tetrahydrobiopterins are enzyme cofactors that carry electrons in redox reactions.

IDA

MF

GO:0034618

arginine binding

Interacting selectively and non-covalently with 2-amino-5-(carbamimidamido)pentanoic acid.

IDA

MF

GO:0046870

cadmium ion binding

Interacting selectively and non-covalently with cadmium (Cd) ions.

NAS

MF

GO:0050660

flavin adenine dinucleotide binding

Interacting selectively and non-covalently with FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2.

NAS

MF

GO:0050661

NADP binding

Interacting selectively and non-covalently with nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH.

NAS

MF

GO:0097110

scaffold protein binding

Interacting selectively and non-covalently with a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes.

IEA

Domain ID Description

IPR001094

Flavodoxin-like

IPR001433

Oxidoreductase FAD/NAD(P)-binding

IPR001709

Flavoprotein pyridine nucleotide cytochrome reductase

IPR003097

FAD-binding, type 1

IPR004030

Nitric oxide synthase, N-terminal

IPR008254

Flavodoxin/nitric oxide synthase

IPR012144

Nitric-oxide synthase, eukaryote

IPR017927

Ferredoxin reductase-type FAD-binding domain

IPR017938

Riboflavin synthase-like beta-barrel

IPR029039

Flavoprotein-like domain

Pathway ID Pathway Term Pathway Source

hsa00220

Arginine biosynthesis

KEGG

hsa00330

Arginine and proline metabolism

KEGG

hsa01100

Metabolic pathways

KEGG

hsa04020

Calcium signaling pathway

KEGG

hsa04022

cGMP-PKG signaling pathway

KEGG

hsa04066

HIF-1 signaling pathway

KEGG

hsa04071

Sphingolipid signaling pathway

KEGG

hsa04151

PI3K-Akt signaling pathway

KEGG

hsa04370

VEGF signaling pathway

KEGG

hsa04371

Apelin signaling pathway

KEGG

hsa04611

Platelet activation

KEGG

hsa04915

Estrogen signaling pathway

KEGG

hsa04921

Oxytocin signaling pathway

KEGG

hsa04931

Insulin resistance

KEGG

hsa04933

AGE-RAGE signaling pathway in diabetic complications

KEGG

hsa05418

Fluid shear stress and atherosclerosis

KEGG

WP437

EGF/EGFR Signaling Pathway

WikiPathways

WP2324

AGE/RAGE pathway

WikiPathways

WP2355

Corticotropin-releasing hormone signaling pathway

WikiPathways

WP3844

PI3K-AKT-mTOR signaling pathway and therapeutic opportunities

WikiPathways

WP289

Myometrial Relaxation and Contraction Pathways

WikiPathways

WP2034

Leptin signaling pathway

WikiPathways

WP1539

Angiogenesis

WikiPathways

WP2197

Endothelin Pathways

WikiPathways

WP1995

Effects of Nitric Oxide

WikiPathways

WP554

ACE Inhibitor Pathway

WikiPathways

WP3932

Focal Adhesion-PI3K-Akt-mTOR-signaling pathway

WikiPathways

WP3888

VEGFA-VEGFR2 Signaling Pathway

WikiPathways

h_no1Pathway

Actions of Nitric Oxide in the Heart

BioCarta

h_gcrPathway

Corticosteroids and cardioprotection

BioCarta

h_hifPathway

Hypoxia-Inducible Factor in the Cardiovascular System

BioCarta

h_raccPathway

Ion Channels and Their Functional Role in Vascular Endothelium

BioCarta

h_vegfPathway

VEGF, Hypoxia, and Angiogenesis

BioCarta

UMLS CUI UMLS Term

C0000832

Abruptio Placentae

C0001418

Adenocarcinoma

C0002395

Alzheimer'S Disease

C0003130

Anoxia

C0003850

Arteriosclerosis

C0004153

Atherosclerosis

C0004238

Atrial Fibrillation

C0007222

Cardiovascular Diseases

C0007785

Cerebral Infarction

C0008924

Cleft Lip

C0008925

Cleft Palate

C0010073

Coronary Artery Vasospasm

C0011853

Diabetes Mellitus, Experimental

C0011854

Diabetes Mellitus, Insulin-Dependent

C0011860

Diabetes Mellitus, Non-Insulin-Dependent

C0011875

Diabetic Angiopathies

C0011881

Diabetic Nephropathy

C0014859

Esophageal Neoplasms

C0015934

Fetal Growth Retardation

C0018800

Cardiomegaly

C0018801

Heart Failure

C0019284

Diaphragmatic Hernia

C0020456

Hyperglycemia

C0020459

Hyperinsulinism

C0020473

Hyperlipidemia

C0020538

Hypertensive Disease

C0020541

Hypertension, Portal

C0020542

Pulmonary Hypertension

C0020545

Hypertension, Renovascular

C0021364

Male Infertility

C0021655

Insulin Resistance

C0021845

Intestinal Perforation

C0022116

Ischemia

C0023893

Liver Cirrhosis, Experimental

C0024117

Chronic Obstructive Airway Disease

C0027051

Myocardial Infarction

C0027055

Myocardial Reperfusion Injury

C0032914

Pre-Eclampsia

C0033578

Prostatic Neoplasms

C0034063

Pulmonary Edema

C0035126

Reperfusion Injury

C0038356

Stomach Neoplasms

C0038358

Gastric Ulcer

C0041948

Uremia

C0042514

Tachycardia, Ventricular

C0042594

Vestibular Diseases

C0151636

Premature Ventricular Contractions

C0151744

Myocardial Ischemia

C0242350

Erectile Dysfunction

C0243026

Sepsis

C0520459

Necrotizing Enterocolitis

C0524620

Metabolic Syndrome X

C0852036

Pregnancy Associated Hypertension

C1458155

Mammary Neoplasms

C1956346

Coronary Artery Disease

C2609414

Acute Kidney Injury

Tissue Cell Type

placenta

trophoblastic cells

Database Name

DisGeNET

DGA

No sources found.

Gene Symbol Entrez ID Uniprot ID Score

PLCG1

5335

P19174

0.00

PLCG2

5336

P16885

0.00

PRKAA2

5563

P54646

0.00

PRKCD

5580

Q05655

0.00

RAC2

5880

P15153

0.00

ROCK1

6093

Q13464

0.00

SRC

6714

P12931

0.00

TGFBR1

7046

P36897

0.00

TGFBR2

7048

P37173

0.00

ROCK2

9475

O75116

0.00

AGTR1

185

P30556

0.52

BDNF

627

P23560

0.52

BDKRB2

624

P30411

0.62

A2M

2

P01023

0.63

CAMK2A

815

Q9UQM7

0.63

CTNNB1

1499

P35222

0.63

ELAVL1

1994

Q15717

0.63

H3F3A; H3F3B

3020

P84243

0.63

PSEN2

5664

P49810

0.63

UMPS

7372

P11172

0.63

TECR

9524

Q9NZ01

0.63

PAXIP1

22976

Q6ZW49

0.63

EFEMP2

30008

O95967

0.63

EXOSC1

51013

Q9Y3B2

0.63

CEP55

55165

Q53EZ4

0.63

RNF32

140545

Q9H0A6

0.63

ACTB

60

P60709

0.68

APP

351

P05067

0.72

GCDH

2639

Q92947

0.77

NOS3

4846

P29474

0.89

HSP90AA1

3320

P07900

0.90

CALML3

810

P27482

0.00

NOS1

4842

P29475

0.00

EDNRB

1910

P24530

0.52

NMT1

4836

P30419

0.52

SP1

6667

P08047

0.55

PPP2R5A

5525

Q15172

0.62

ACTN4

81

O43707

0.63

ACTN2

88

P35609

0.63

ELAVL3

1995

Q14576

0.63

ESR1

2099

P03372

0.63

EFEMP1

2202

Q12805

0.63

GOLGA2

2801

Q08379

0.63

MAGEA11

4110

P43364

0.63

HTRA1

5654

Q92743

0.63

PSEN1

5663

P49768

0.63

HDAC3

8841

O15379

0.63

IMMT

10989

Q16891

0.63

MAST1

22983

Q9Y2H9

0.63

MPRIP

23164

Q6WCQ1

0.63

SIRT1

23411

Q96EB6

0.63

KANK2

25959

Q63ZY3

0.63

FIS1

51024

Q9Y3D6

0.63

TXNDC11

51061

Q6PKC3

0.63

EXOC6

54536

Q8TAG9

0.63

RNF31

55072

Q96EP0

0.63

PI4K2A

55361

Q9BTU6

0.63

APOE

348

P02649

0.68

ST13

6767

P50502

0.76

CDC37

11140

Q16543

0.77

GUCY1B3

2983

Q02153

0.78

AKT1

207

P31749

0.80

CAV1

857

Q03135

0.84

NOSIP

51070

Q9Y314

0.86

NOSTRIN

115677

Q8IVI9

0.89

CALM2

805

P62158

0.90

CALM3

808

P62158

0.90